zrrsys

Adagio a nice buy

Long
NASDAQ:ADGI   None
Adagio is a clinical-stage biopharmaceutical company
heavy buying around that price
set sl under the curve

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.